Genflow Biosciences (LON:GENF) Shares Up 6.5% – Still a Buy?

Shares of Genflow Biosciences plc (LON:GENF) shot up 6.5% on Monday . The stock traded as high as GBX 2.50 and last traded at GBX 2.34. 3,210,860 shares changed hands during mid-day trading, an increase of 18% from the average session volume of 2,723,433 shares. The stock had previously closed at GBX 2.20.

Genflow Biosciences Price Performance

The stock has a market capitalization of £13.39 million, a P/E ratio of -4.98 and a beta of 2.24. The firm has a fifty day moving average of GBX 1.93 and a two-hundred day moving average of GBX 1.90.

About Genflow Biosciences

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.